| Period Ending: |
LTM
(Last Twelve Months) |
2022 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2023-03-31 | 2023-03-31 | 2022-03-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 1.81 | 1.81 | 0.158 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 1.81 | 1.81 | 0.158 |
| Other Operating Expenses | -0.001 | 0 | -0 |
| Operating Income | -1.81 | -1.81 | -0.158 |
| Net Non-Operating Interest | 0.608 | 0 | 0.249 |
| Interest Income | 0.608 | 0 | 0 |
| Interest Expense | 0 | 0 | -0.249 |
| Equity & Other Income/(Expense) | 19.19 | 19.8 | -0.001 |
| Income Before Tax | 17.98 | 17.98 | 0.09 |
| Income Tax Expense | -19.8 | -19.8 | -0.249 |
| Income Attributable to Non-Controlling Interest | -0 | 0 | 0 |
| Net Income | 37.78 | 37.78 | 0.339 |
| Depreciation and Amortization | -19.91 | -19.8 | 0.249 |
| EBITDA | -21.72 | -21.61 | 0.091 |
| Earnings Per Share (EPS) | 3.37 | 1.89 | 0.014 |
| Diluted Earnings Per Share | 1.51 | 1.89 | 0.014 |
| Weighted Average Shares Outstanding | 25 | 20 | 25 |
| Diluted Weighted Average Shares Outstanding | 25 | 20 | 25 |
